We are live on ! Find out more
CC

Centiva Capital Portfolio holdings

AUM $11.5B
1-Year Est. Return 31.97%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+31.97%
3 Year Est. Return
+65.13%
5 Year Est. Return
+86.06%
10 Year Est. Return
AUM
$4.85B
AUM Growth
+$3.26B
Cap. Flow
-$286M
Cap. Flow %
-5.9%
Top 10 Hldgs %
28.38%
Holding
1,688
New
454
Increased
398
Reduced
96
Closed
544

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$322M
2
IBM icon
IBM
IBM
+$18.6M
3
CSCO icon
Cisco
CSCO
+$17.6M
4
META icon
Meta Platforms (Facebook)
META
+$17.4M
5
AMRC icon
Ameresco
AMRC
+$12.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.11%
2 Financials 7.93%
3 Technology 2.56%
4 Healthcare 1.8%
5 Consumer Discretionary 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGPI
551
CALL
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$1.17M 0.02%
+100,000
New +$1.15M
FSLY icon
552
CALL
Fastly Inc
FSLY
$3.64B
$1.17M 0.02%
32,900
+32,010
+3,597% +$1.39M
CVNA icon
553
CALL
Carvana
CVNA
$53.5B
$1.16M 0.02%
25,000
+22,750
+1,011% +$1.25M
CI icon
554
CALL
Cigna
CI
$73.5B
$1.15M 0.02%
5,000
+4,500
+900% +$956K
KEY icon
555
KeyCorp
KEY
$23.4B
$1.14M 0.02%
49,260
+5,920
+14% +$137K
TFC icon
556
Truist Financial
TFC
$61.4B
$1.14M 0.02%
19,384
+2,775
+17% +$170K
BLDR icon
557
Builders FirstSource
BLDR
$7.23B
$1.13M 0.02%
+13,227
New +$896K
MNST icon
558
CALL
Monster Beverage
MNST
$91.8B
$1.13M 0.02%
47,200
+44,200
+1,473% +$982K
MNST icon
559
PUT
Monster Beverage
MNST
$91.8B
$1.13M 0.02%
47,200
+44,200
+1,473% +$982K
RRD
560
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$1.13M 0.02%
+100,000
New +$867K
AMGN icon
561
CALL
Amgen
AMGN
$233B
$1.13M 0.02%
+5,000
New +$1.06M
AMGN icon
562
PUT
Amgen
AMGN
$233B
$1.13M 0.02%
+5,000
New +$1.06M
BPACU
563
DELISTED
Bullpen Parlay Acquisition Company Unit
BPACU
$1.12M 0.02%
+110,000
New +$1.11M
NVAX icon
564
CALL
Novavax
NVAX
$1.47B
$1.12M 0.02%
7,800
+6,910
+776% +$1.19M
JNJ icon
565
Johnson & Johnson
JNJ
$642B
$1.11M 0.02%
6,464
+1,465
+29% +$240K
VRTX icon
566
CALL
Vertex Pharmaceuticals
VRTX
$137B
$1.1M 0.02%
+5,000
New +$972K
VRTX icon
567
PUT
Vertex Pharmaceuticals
VRTX
$137B
$1.1M 0.02%
+5,000
New +$972K
BERY
568
DELISTED
Berry Global Group, Inc.
BERY
$1.1M 0.02%
+16,203
New +$1M
INMD icon
569
InMode
INMD
$855M
$1.09M 0.02%
+15,485
New +$1.24M
BYND icon
570
CALL
Beyond Meat
BYND
$238M
$1.08M 0.02%
553
+543
+5,430% +$1.39M
AMBA icon
571
Ambarella
AMBA
$3.11B
$1.08M 0.02%
+5,310
New +$984K
BBY icon
572
PUT
Best Buy
BBY
$17.4B
$1.07M 0.02%
10,500
+9,450
+900% +$1.08M
FRC
573
DELISTED
First Republic Bank
FRC
$1.06M 0.02%
5,123
-1,882
-27% -$397K
TDOC icon
574
CALL
Teladoc Health
TDOC
$1.19B
$1.06M 0.02%
11,500
+10,000
+667% +$1.2M
MDT icon
575
Medtronic
MDT
$117B
$1.05M 0.02%
10,200
+7,508
+279% +$869K

Similar funds

Centiva Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Centiva Capital held 1,688 positions worth $4.85B, up 205% from $1.59B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Centiva Capital withdrew a net $286M in Q4 2021, closing 544 positions and reducing 96 holdings. Its most notable exit was Apple, an estimated $322M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 40% a quarter earlier, followed by Financials and Technology.

Against the trend, Centiva Capital opened a new position in Invesco QQQ Trust worth $138M.

  • Centiva Capital's largest Q4 2021 buy was Invesco QQQ Trust: 347,770 shares worth $138M.
  • Centiva Capital added most to Pershing Square Tontine Holdings, Ltd. in Q4 2021, an estimated $28M increase.
  • Centiva Capital's biggest Q4 2021 reduction was IBM, cutting an estimated $18.6M.
  • Centiva Capital fully exited Apple in Q4 2021, selling an estimated $322M.
  • Centiva Capital's ten largest holdings make up 28% of its $4.85B portfolio in Q4 2021.
  • Centiva Capital opened 454 new positions and closed 544 in Q4 2021.
  • Centiva Capital's portfolio value rose 205% quarter-over-quarter to $4.85B.

Based on Centiva Capital's 13F filing for Q4 2021, filed 14 Feb 2022.